AMBER JOBE: Open Payments
NPI 1700261161 · TIMONIUM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,164 in 396 payments from 33 companies in 2025. Trend: 2023 $6,919 · 2024 $3,751 · 2025 $11,164
Food & beverage: $7,838Speaker / faculty: $3,130Education: $196
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 117 | $4,560 |
| Amgen Inc. | 24 | $891 |
| PFIZER INC. | 42 | $812 |
| Biogen, Inc. | 32 | $809 |
| Teva Pharmaceuticals USA, Inc. | 18 | $595 |
| Axsome Therapeutics, Inc. | 18 | $397 |
| Lundbeck LLC | 18 | $357 |
| Neurocrine BioSciences, Inc. | 10 | $296 |
| ANI Pharmaceuticals, Inc. | 12 | $273 |
| Celgene Corporation | 17 | $245 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, TYSABRI, UPLIZNA, AUSTEDO XR, VYEPTI, INGREZZA.
Industry payments across MD — which companies pay providers there.
